{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:37:07Z","timestamp":1784230627826,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.pdpdt.2024.103998","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T16:40:04Z","timestamp":1706978404000},"page":"103998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Potential therapeutic efficacy of photodynamic therapy on female hormonal-dependent cancers in a hormonal simulated microenvironment"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-6909","authenticated-orcid":false,"given":"Ellie Shihng-meir","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky Wing-kei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pdpdt.2024.103998_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2010.09.008","article-title":"Steroid hormone receptors in cancer development: a target for cancer therapeutics","volume":"300","author":"Ahmad","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/243298","article-title":"Potential therapeutic targets in uterine sarcomas","volume":"2015","author":"Cuppens","year":"2015","journal-title":"Sarcoma"},{"key":"10.1016\/j.pdpdt.2024.103998_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.steroids.2016.12.011","article-title":"The role of sex hormones and steroid receptors on female reproductive cancers","volume":"118","author":"Chuffa","year":"2017","journal-title":"Steroids"},{"issue":"10","key":"10.1016\/j.pdpdt.2024.103998_bib0004","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","article-title":"Assessing women at high risk of breast cancer: a review of risk assessment models","volume":"102","author":"Amir","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0005","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00404-013-2784-1","article-title":"Ovarian epithelial tumors and reproductive factors: a systematic review","volume":"287","author":"Schuler","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jsbmb.2014.06.001","article-title":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","volume":"145","author":"Labrie","year":"2015","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"9980","key":"10.1016\/j.pdpdt.2024.103998_bib0007","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.103998_bib0008","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.pdpdt.2024.103998_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/era.12.172","article-title":"Chemotherapy regimens in early breast cancer: major controversies and future outlook","volume":"13","author":"Joerger","year":"2013","journal-title":"Expert. Rev. AntiCancer Ther."},{"issue":"5","key":"10.1016\/j.pdpdt.2024.103998_bib0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10147-012-0459-8","article-title":"Clinical trials and future potential of targeted therapy for ovarian cancer","volume":"17","author":"Itamochi","year":"2012","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0011","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpobgyn.2011.06.002","article-title":"Prognostic factors in uterine sarcoma","volume":"25","author":"Gadducci","year":"2011","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0012","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.breast.2016.09.016","article-title":"Photodynamic therapy: inception to application in breast cancer","volume":"31","author":"Banerjee","year":"2017","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.pdpdt.2024.103998_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8100088","article-title":"Photodynamic therapy in gynecologic malignancies: a review of the roswell park cancer institute experience","volume":"8","author":"Mayor","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.pdpdt.2024.103998_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2009.04.001","article-title":"Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT","volume":"96","author":"Robertson","year":"2009","journal-title":"J. Photochem. Photobiol. B"},{"issue":"7","key":"10.1016\/j.pdpdt.2024.103998_bib0015","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1039\/c0pp00147c","article-title":"Targeted photodynamic therapy-a promising strategy of tumor treatment","volume":"10","author":"Bugaj","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0016","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1562\/2006-02-03-IR-794","article-title":"5-ALA derivatives in photomedicine: characteristics, application and perspectives","volume":"82","author":"Fotinos","year":"2006","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0017","first-page":"1481","article-title":"Use of 5-ALA esters to improve photodynamic therapy on cells in culture","volume":"57","author":"Gaullier","year":"1997","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.103998_bib0018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pdpdt.2010.12.002","article-title":"Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines","volume":"8","author":"Wu","year":"2011","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0019","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1751-1097.2009.00543.x","article-title":"siRNA mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines","volume":"85","author":"Miyake","year":"2009","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2005.10.019","article-title":"Mechanisms involved in ALA-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin","volume":"71","author":"Ohgari","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.103998_bib0021","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.intimp.2010.11.029","article-title":"Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy","volume":"11","author":"Ishizuka","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0022","doi-asserted-by":"crossref","first-page":"485e95","DOI":"10.1038\/sj.bjc.6603273","article-title":"Methotrexate used in combination with A for photodynamic killing of prostate cancer cells","volume":"95","author":"Sinha","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pdpdt.2024.103998_bib0023","doi-asserted-by":"crossref","first-page":"3333e43","DOI":"10.1158\/1078-0432.CCR-08-3054","article-title":"Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo","volume":"15","author":"Anand","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.103998_bib0024","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/lsm.21154","article-title":"The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells","volume":"44","author":"Yoon","year":"2012","journal-title":"Lasers Surg. Med."},{"issue":"3 Pt A","key":"10.1016\/j.pdpdt.2024.103998_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejpb.2013.01.022","article-title":"Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells","volume":"85","author":"Chung","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.pdpdt.2024.103998_bib0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pdpdt.2014.03.001","article-title":"Synergistic apoptotic effect of Doxil\u00ae and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells","volume":"11","author":"Zakaria","year":"2014","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.pdpdt.2024.103998_bib0027","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pdpdt.2013.03.003","article-title":"The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer","volume":"10","author":"Fukuhara","year":"2013","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102620","article-title":"Photodynamic therapy for early-stage cervical cancer treatment","volume":"37","author":"Afanasiev","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.pdpdt.2024.103998_bib0029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pdpdt.2007.07.003","article-title":"Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model","volume":"4","author":"Ascencio","year":"2007","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.pdpdt.2024.103998_bib0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajog.2014.10.1107","article-title":"A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1\/2","volume":"212","author":"Hillemanns","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl 1","key":"10.1016\/j.pdpdt.2024.103998_bib0031","first-page":"123","article-title":"Effect of 5-aminolevulinic acid (ALA) doses and oestrogen\/progesterone on protoporphyrin IX (ppIX) accumulation in human endometrial epithelial cells","volume":"49","author":"Butowska","year":"2004","journal-title":"Rocz. Akad. Med. Bialymst."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.103998_bib0032","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/lsm.20139","article-title":"Influence of the menstrual cycle on aminolevulinic acid induced protoporphyrin IX fluorescence in the endometrium: in vivo study","volume":"36","author":"Degen","year":"2005","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.103998_bib0033","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pdpdt.2010.12.003","article-title":"Photodiagnosis and photodynamic therapy of endometriotic epithelial cells using 5-aminolevulinic acid and steroids","volume":"8","author":"Wo\u0142u\u0144-Cholewa","year":"2011","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0034","first-page":"184","article-title":"Photodynamic diagnosis (PDD) using 5-aminolevulinic acid-supplemented cultures of human endometrial epithelial cells","volume":"51","author":"Wo\u0142u\u0144-Cholewa","year":"2006","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0035","doi-asserted-by":"crossref","first-page":"S1339","DOI":"10.1016\/j.annonc.2020.10.242","article-title":"248P The effect of progesterone on ALA-based PDT efficacy in uterine sarcoma cells","volume":"31","author":"Chu","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101801","article-title":"Evaluation of the effect of 5-aminolevulinic acid hexyl ester (H-ALA) PDT on EBV LMP1 protein expression in human nasopharyngeal cells","volume":"30","author":"Wu","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101945","article-title":"Effect of Foslip\u00ae mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells","volume":"31","author":"Wu","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.103998_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxlet.2008.06.860","article-title":"Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells","volume":"181","author":"Chu","year":"2008","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.103998_bib0039","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<1062::AID-IJC22>3.0.CO;2-5","article-title":"Hormonal modulation of the accumulation of 5-aminolevulinic acid-induced protoporphyrin and phototoxicity in prostate cancer cells","volume":"72","author":"Momma","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.103998_bib0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pdpdt.2010.12.003","article-title":"Photodiagnosis and photodynamic therapy of endometriotic epithelial cells using 5-aminolevulinic acid and steroids","volume":"8","author":"Wo\u0142u\u0144-Cholewa","year":"2011","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"12","key":"10.1016\/j.pdpdt.2024.103998_bib0041","doi-asserted-by":"crossref","first-page":"20516","DOI":"10.18632\/oncotarget.16388","article-title":"Correction: Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2\u03b1 in invasive breast cancer cells","volume":"8","author":"Fuady","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pdpdt.2024.103998_bib0042","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pdpdt.2017.04.003","article-title":"Expression of coproporphyrinogen oxidase is associated with detection of upper gastrointestinal carcinomas by 5-aminolevulinic acid-mediated photodynamic diagnosis","volume":"19","author":"Ogihara","year":"2017","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.103998_bib0043","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pdpdt.2014.05.001","article-title":"Improve efficacy of topical ALA-PDT by calcipotriol through up-regulation of coproporphyrinogen oxidase","volume":"11","author":"Yang","year":"2014","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0044","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1158\/0008-5472.CAN-11-0805","article-title":"Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy","volume":"71","author":"Anand","year":"2011","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.pdpdt.2024.103998_bib0045","first-page":"1723","article-title":"Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo","volume":"55","author":"Hua","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0046","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41416-019-0516-4","article-title":"In order for the light to shine so brightly, the darkness must be present\u2014why do cancers fluoresce with 5-aminolaevulinic acid?","volume":"121","author":"McNicholas","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"1-2","key":"10.1016\/j.pdpdt.2024.103998_bib0047","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2005.10.019","article-title":"Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin","volume":"71","author":"Ohgari","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122351","article-title":"The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid","volume":"10","author":"Hayashi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pdpdt.2024.103998_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115031","article-title":"Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines","volume":"200","author":"Mansi","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.pdpdt.2024.103998_bib0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1158\/0008-5472.CAN-15-1484","article-title":"Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma","volume":"76","author":"Fujita","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.pdpdt.2024.103998_bib0051","doi-asserted-by":"crossref","first-page":"13298","DOI":"10.1038\/srep13298","article-title":"ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy","volume":"5","author":"Palasuberniam","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.pdpdt.2024.103998_bib0052","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.nucmedbio.2010.12.012","article-title":"Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography","volume":"38","author":"Yamasaki","year":"2011","journal-title":"Nucl. Med. Biol."},{"issue":"12","key":"10.1016\/j.pdpdt.2024.103998_bib0053","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1002\/cnr2.1278","article-title":"Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances","volume":"5","author":"Mastrangelopoulou","year":"2022","journal-title":"Cancer Rep."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100024000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100024000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:46:55Z","timestamp":1736304415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100024000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":53,"alternative-id":["S1572100024000371"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.103998","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential therapeutic efficacy of photodynamic therapy on female hormonal-dependent cancers in a hormonal simulated microenvironment","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.103998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103998"}}